“I feel happy,” the soft-spoken senior told Canada’s CTV News, speaking through a translator at a hospital in Portugal. “I’ve spent these years without hardship and without troubles.”
The U.S. Food and Drug Administration approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the ...
The New York Times: HIV Is Reported Cured in a Second Patient, a Milestone in the Global AIDS Epidemic
Scientists have long tried to duplicate the procedure that led to the first long-term remission 12 years ago. With the so-called London patient, they seem to have succeeded.
Gilead Sciences Launches Age Positively Initiative to Address Unique Challenges of Aging Population Living with HIV
Initiative to Provide $17.6 Million to 30 U.S. Organizations to Elevate the Work of Community Groups and Provide Support Needed to Strengthen Care for People Aging with HIV
How one boy is tackling stereotypes in Kazakhstan.
Peng Liyuan, wife of President Xi Jinping, expressed support on Monday for the Bill & Melinda Gates Foundation's efforts to strengthen cooperation with China, as well as third parties, in capacity building medical professionals for China and the world, when meeting with Bill Gates, the ...
A dual antiretroviral regimen containing dolutegravir (Tivicay) and boosted darunavir (Prezista) maintains viral suppression in most people who switch from a suppressive three-drug regimen, according to an observational study presented at the recent IDWeek in San Francisco. However, two drugs may not be enough for ...
Call for submissions: Good practices on the long-term health, well-being and chronic care of people living with HIV
Following the launch of multi-stakeholder recommendations in 2017, HIV Outcomes is calling for good practice examples from across the WHO Europe region on the long-term health, well-being and chronic care of people living with HIV for publication in an online compendium.
Svetlana Izambaeva was one of the first women living with HIV in Russia who was brave enough to open her face. Now Svetlana supports other people living with HIV.
Andrey, activist, peer consultant: “When I learned that I have HIV and TB, I thought this is the end!”
We continue the series of special interviews by Natasha Sidorenko “Real stories of living with HIV and overcoming TB”.
This year’s theme for World AIDS Day, which will be marking its 30th anniversary on 1 December, will be “Know your status”.
This booklet provides information on living well with HIV as you get older.
HIV-positive activist from Russia: “It is important that the doctor says it’s not the end, you still have a chance”
We continue the series of special feature interviews by Natasha Sidorenko "Life stories about living with HIV and overcoming tuberculosis".
A group based behavioral intervention reduced the sexual risk for HIV infection and transmission by nearly 40% in young transgender women, according to new findings published in JAMA Pediatrics.
The Eurasian Women's Network on AIDS is launching the "HIV Is Not a Crime" awareness campaign, which aims to draw attention to the situation with the criminalization of HIV transmission in the Eastern Europe and Central Asia region.
Svitlana Moroz is a Ukrainian women’s rights activist living with HIV. She is one of the founders of the Union of Women of Ukraine affected by HIV “Positive Women” and since 2013 she has coordinated activities for the Eurasian Women’s Network on AIDS.
This first compendium of good HIV practices in the WHO European Region includes 52 practice examples from 32 Member States.
Called ESTICOM (European Surveys and Trainings to Improve MSM Community Health) the partnership will deliver on three inter-linked projects over three years from August 2016 to August 2019.